38 Roussel and associates 39 found a significant positive correlation between plasma glucose levels and plasma malondyaldehyde (MDA), a measure of lipid peroxidation, in people with metabolic syndrome
GLOW is adequate when skin is calm and the goal is firmness, fine lines, or texture
Ro emphasizes rapid access to brand-name GLP-1 medications through asynchronous provider consultations
These medications carry a boxed warning about thyroid C-cell tumors (contraindicated with personal/family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2) and warnings about potential risks including pancreatitis, gallbladder disease, acute kidney injury with dehydration, and worsening diabetic retinopathy with rapid glucose reduction (particularly with semaglutide)
Dehydration, electrolyte shifts, and rapid weight loss are the primary mechanisms